Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

An Audience With in 2014

Filter By:

Article Type
Year

  • Wayne Koff, Chief Scientific Officer at the International AIDS Vaccine Initiative, discusses the imminent launch of the Human Vaccines Project.

    An Audience With

  • Doug Williams, head of Research and Development at Biogen Idec, discusses remyelinating agents, Alzheimer's disease drugs and gene therapy.

    An Audience With

  • Keith Blundy, Chief Executive Officer of Cancer Research Technology, discusses new developments at the non-profit Cancer Research UK.

    An Audience With

  • Story Landis, ex-Director of the US National Institute of Neurological Disorders and Stroke, discusses how she has worked to address a crisis of basic research funding at the Institute.

    An Audience With

  • Bob More, venture capitalist with the Bill and Melinda Gates Foundation, discusses the challenges of aligning financial and philanthropic interests.

    An Audience With

  • Steve Blank, a serial entrepreneur, discusses the need for more focus on commercialization at even the earliest stages of a startups life cycle.

    An Audience With

  • Tatsuya Kondo, chief executive of the PMDA, discusses the tenth anniversary of the Japanese regulatory authority.

    An Audience With

  • The FDA's Tatiana Prowell discusses some of the most common pitfalls in oncology drug development.

    An Audience With

  • John P. A. Ioannidis, Professor of Medicine, Health Research and Policy and Statistics at Stanford University, discusses his latest plans to tackle irreproducibility in science.

    An Audience With

  • Wolfgang Plischke, Bayer's outgoing chief of innovation, discusses R&D funding and the intersection of human, animal and plant research.

    An Audience With

  • John Reed, Head of Pharma Research & Early Development at Roche, discusses his plans to tweak the therapeutic focus, clinical development strategy and externalization of innovation at Roche.

    An Audience With

  • Mads Krogsgaard Thomsen celebrates his twentieth anniversary of overseeing R&D at Novo Nordisk.

    An Audience With

Search

Advanced search

Quick links